Alliance is a central element of our growth strategy. We actively seek partnering opportunities through business development and licensing efforts.
Rooted in China, Eddingpharm developed deep market access expertise and superior marketing and sales efficiency. From 2003 to 2008, Eddingpharm’s compound annual growth rate of sales is 42%, double that of industry average. With 23 district offices, 400 professional sales representatives and more than 1000 hospitals of reach, Eddingpharm became the partner of choice for many renowned corporations. Second and third collaborations with the same partner are not unusual for us, a tangible proof that good relationships grow.
If your company has marketed products and wishes to enter Chinese market, Eddingpharm can help you navigate through the complex market access process - registration, clinical trials, pricing, reimbursement, tendering and hospital listing. If your company has late stage compounds and wishes to develop the product in China, Eddingpharm is willing and capable to invest. If you already have presence in China but wishes to revitalize sales, Eddingpharm’s extensive sales and distribution network can help you boost performance.
We especially encourage you to consider partnering in Oncology, Parenteral and Enteral nutrition and Anti-infection. Other areas of interest include gastrointestinal and respiratory. For all partnership enquiries please contact:
William Liang
Business Development Director
Building No.2, 130 Zhijiang Road
Shanghai, China. 200070